Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunekos is an Italian aesthetic medicine company that specializes in the bioregeneration of the extracellular matrix (ECM). Developed by Professional Dietetics, the company's products utilize a patented formula known as HY6AA, which combines non-cross-linked hyaluronic acid with a specific cluster of six amino acids. This unique composition is designed to stimulate the internal production of collagen and elastin, effectively treating skin aging and laxity from a physiological level. Sunekos offers a diverse portfolio of injectable treatments, including Sunekos 200 and Sunekos 1200, which are used to address wrinkles, dark circles, and loss of facial volume. The company's approach focuses on restoring the skin's natural elasticity and hydration through cellular stimulation rather than simple volume replacement.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sunekos.